FLT3 and acute myeloid leukemia: Here, we identified selective Akt inhibitors, such as MK2206, as able to effectively combine with FLT3 inhibitors, including PKC412 and AC220, against mutant FLT3-expressing cell lines or primary AML cells cultured in a cytoprotective stromal environment.